{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:36:26Z","timestamp":1765438586796},"reference-count":26,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Mol Med"],"DOI":"10.3892\/ijmm.2019.4375","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T08:57:28Z","timestamp":1571389048000},"source":"Crossref","is-referenced-by-count":9,"title":["Role and mechanisms of action of microRNA\u201121 as regards the regulation of the WNT\/\u03b2\u2011catenin signaling pathway in the pathogenesis of non\u2011alcoholic fatty liver disease"],"prefix":"10.3892","author":[{"given":"Xiu\u2011Mei","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The First People's Hospital of Neijiang, Neijiang, Sichuan 641000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao\u2011Yi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second People's Hospital of Yibin, Yibin, Sichuan 644000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu\u2011Mei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mu\u2011Han","family":"L\ufffd","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang\u2011Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,10,18]]},"reference":[{"key":"key20200713171437_b1-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: Pathogenesis and disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"key20200713171437_b2-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/med.21515","article-title":"Progress and challenges in the prevention and control of nonalcoholic fatty liver disease","volume":"39","author":"Cai","year":"2019","journal-title":"Med Res Rev"},{"key":"key20200713171437_b3-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.phrs.2018.07.014","article-title":"Future trends in the treatment of non-alcoholic steatohepatitis","volume":"134","author":"Fiorucci","year":"2018","journal-title":"Pharmacol Res"},{"key":"key20200713171437_b4-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1479164117738442","article-title":"Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases","volume":"15","author":"Ackers","year":"2018","journal-title":"Diab Vasc Dis Res"},{"key":"key20200713171437_b5-ijmm-44-06-2201","article-title":"Studying non-alcoholic fatty liver disease: The ins and outs of in vivo, ex vivo and in vitro human models","volume":"11","author":"Green","year":"2018","journal-title":"Horm Mol Biol Clin Investig Aug"},{"key":"key20200713171437_b6-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.3390\/nu7064453","article-title":"Low-density lipoprotein receptor-related protein 6 (LRP6) is a novel nutritional therapeutic target for hyperlip-idemia, non-alcoholic fatty liver disease, and atherosclerosis","volume":"7","author":"Go","year":"2015","journal-title":"Nutrients"},{"key":"key20200713171437_b7-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1096\/fj.15-271171","article-title":"Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a","volume":"29","author":"Wang","year":"2015","journal-title":"FASEB J"},{"key":"key20200713171437_b8-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/mnfr.201200182","article-title":"Lycopene inhibits hepatic steatosis via microRNA-21-induced downregulation of fatty acid-binding protein 7 in mice fed a high-fat diet","volume":"56","author":"Ahn","year":"2012","journal-title":"Mol Nutr Food Res"},{"key":"key20200713171437_b9-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3892\/ijmm.2015.2076","article-title":"miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR","volume":"35","author":"Sun","year":"2015","journal-title":"Int J Mol Med"},{"key":"key20200713171437_b10-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1136\/gutjnl-2014-308883","article-title":"Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPAR\u03b1 expression","volume":"65","author":"Loyer","year":"2016","journal-title":"Gut"},{"key":"key20200713171437_b11-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"G298","DOI":"10.1152\/ajpgi.00346.2014","article-title":"Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis","volume":"308","author":"Dattaroy","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"key20200713171437_b12-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.biopha.2013.03.014","article-title":"MicroRNA-21 activates hepatic stellate cells via PTEN\/Akt signaling","volume":"67","author":"Wei","year":"2013","journal-title":"Biomed Pharmacother"},{"key":"key20200713171437_b13-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1136\/gutjnl-2014-308430","article-title":"MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepa-tocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway","volume":"65","author":"Wu","year":"2016","journal-title":"Gut"},{"key":"key20200713171437_b14-ijmm-44-06-2201","first-page":"715","article-title":"Mutation of miR-21 targets endogenous lipoprotein receptor-related protein 6 and nonalcoholic fatty liver disease","volume":"9","author":"Li","year":"2017","journal-title":"Am J Transl Res"},{"key":"key20200713171437_b15-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"key20200713171437_b16-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713171437_b17-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.bbrc.2018.06.027","article-title":"Hepatocyte-specific deletion of Brg1 alleviates methionine-and-choline-deficient diet (MCD) induced non-alcoholic steatohepatitis in mice","volume":"503","author":"Kong","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713171437_b18-ijmm-44-06-2201","first-page":"144","article-title":"Roles of microRNA-21 in the pathogenesis of insulin resistance and diabetic mellitus-induced non-alcoholic fatty liver disease","volume":"38","author":"Zhao","year":"2016","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"key20200713171437_b19-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","article-title":"Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver","volume":"424","author":"Yamada","year":"2013","journal-title":"Clin Chim Acta"},{"key":"key20200713171437_b20-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"e0142661","DOI":"10.1371\/journal.pone.0142661","article-title":"Performance of serum microRNAs -122, -192 and -21 as biomarkers in patients with non-alcoholic steatohepatitis","volume":"10","author":"Becker","year":"2015","journal-title":"PLoS One"},{"key":"key20200713171437_b21-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"e2748","DOI":"10.1038\/cddis.2017.172","article-title":"miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice","volume":"8","author":"Rodrigues","year":"2017","journal-title":"Cell Death Dis"},{"key":"key20200713171437_b22-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1042\/CS20160334","article-title":"Inhibiting miR-21 attenuates experimental hepatic fibrosis by suppressing both the ERK1 pathway in HSC and hepatocyte EMT","volume":"130","author":"Wu","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"key20200713171437_b23-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1002\/hep.29627","article-title":"MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis","volume":"67","author":"Caviglia","year":"2018","journal-title":"Hepatology"},{"key":"key20200713171437_b24-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/ahg.12254","article-title":"The association of LRP6 rs2302685 (V1062I) polymorphism with the risk of hyperlipidemia in Iranian children and adolescents","volume":"82","author":"Montazeri-Najafabady","year":"2018","journal-title":"Ann Hum Genet"},{"key":"key20200713171437_b25-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cmet.2013.11.023","article-title":"The combined hyperlip-idemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue","volume":"19","author":"Go","year":"2014","journal-title":"Cell Metab"},{"key":"key20200713171437_b26-ijmm-44-06-2201","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s00018-018-2838-4","article-title":"Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation","volume":"75","author":"Silva","year":"2018","journal-title":"Cell Mol Life Sci"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T17:57:28Z","timestamp":1594663048000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2019.4375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,18]]},"references-count":26,"URL":"https:\/\/doi.org\/10.3892\/ijmm.2019.4375","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,18]]}}}